Annual EBITDA
-$1.11B$292.00M-35.86%
Summary
- Current Value
- As of today, ROIV annual EBITDA is -$1.11B, down -35.86% on
- Historical Performance
- ROIV annual EBITDA is down -21.47% over the past 3 years, with unknown 5-year change
- All-Time High Comparison
- ROIV annual EBITDA is currently -35.86% below its historical high of -$814.35M set on
- 3-Year Low Comparison
- ROIV annual EBITDA is at its 3-year low
- Sector Comparison
- ROIV annual EBITDA is higher than 0.25% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$1.11B | -35.9% | -21.5% | – | – | |
| Quarterly EBITDA | -$305.31M | +10.9% | -10.7% | +16.5% | – | |
| TTM EBITDA | -$1.15B | -17.6% | -23.4% | -213.2% | – | |
| Price | $23.19 | +115.9% | +134.9% | +121.5% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $29.05M | -11.2% | -47.5% | -57.1% | +1150.1% | |
| Annual EPS | -$0.24 | -104.5% | +81.2% | -104.5% | +95.1% | |
| Annual EBIT | -$1.11B | -35.0% | +8.1% | -109.2% | -48.8% | |
| Annual Net Income | -$729.76M | -116.0% | +21.0% | -28.4% | +9.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$814.35M | -35.9% | |
| 5Y | -$814.35M | -35.9% | |
| All | -$814.35M | -35.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.11B | at low | |
| 5Y | -$1.11B | at low | |
| All | -$1.11B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$1.11B | -35.9% | |
| -$814.35M | +22.5% | |
| -$1.05B | -15.4% |
| Year | Value | Change |
|---|---|---|
| -$910.77M | -1.7% | |
| -$895.74M | - |
FAQ
What is the current annual EBITDA of ROIV?
As of today, ROIV annual EBITDA is -$1.11B
What is 1-year change in ROIV annual EBITDA?
ROIV annual EBITDA is down -35.86% year-over-year
What is 3-year change in ROIV annual EBITDA?
ROIV annual EBITDA is down -21.47% over the past 3 years
How far is ROIV annual EBITDA from its all-time high?
ROIV annual EBITDA is currently -35.86% below its historical high of -$814.35M set on March 31, 2024
How does ROIV annual EBITDA rank versus sector peers?
ROIV annual EBITDA is higher than 0.25% of companies in Healthcare sector
When is ROIV next annual earnings release?
As of today, the next annual earnings release for ROIV has not been scheduled
Quarterly EBITDA
-$305.31M$21.49M-7.57%
Summary
- Current Value
- As of today, ROIV quarterly EBITDA is -$305.31M, down -7.57% on
- Historical Performance
- ROIV quarterly EBITDA is up +10.89% year-over-year, and down -10.74% over the past 3 years
- All-Time High Comparison
- ROIV quarterly EBITDA is currently -143.85% below its historical high of -$125.20M set on
- 3-Year Low Comparison
- ROIV quarterly EBITDA is +10.89% above its 3-year low of -$342.63M reached on
- Sector Comparison
- ROIV quarterly EBITDA is higher than 0.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$305.31M | -7.6% | +10.9% | -10.7% | +16.5% | |
| Annual EBITDA | -$1.11B | – | -35.9% | -21.5% | – | |
| TTM EBITDA | -$1.15B | +3.2% | -17.6% | -23.4% | -213.2% | |
| Price | $23.19 | +43.1% | +115.9% | +134.9% | +121.5% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.57M | -27.6% | -64.9% | -87.5% | -89.6% | |
| Quarterly EPS | -$0.17 | +49.2% | +46.7% | +60.0% | +92.7% | |
| Quarterly EBIT | -$306.23M | -7.5% | +10.4% | -9.1% | +43.4% | |
| Quarterly Net Income | -$166.04M | +39.4% | +29.9% | +47.4% | +70.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$272.44M | N/A | -12.1% |
| 3Y | -$201.68M | -51.4% | |
| 5Y | -$125.20M | -143.8% | |
| All | -$125.20M | -143.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$305.31M | at low | |
| 3Y | -$342.63M | +10.9% | |
| 5Y | -$684.43M | +55.4% | |
| All | -$684.43M | +55.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ROIV?
As of today, ROIV quarterly EBITDA is -$305.31M
What is ROIV quarterly EBITDA most recent change?
ROIV quarterly EBITDA was down -7.57% on September 30, 2025
What is 1-year change in ROIV quarterly EBITDA?
ROIV quarterly EBITDA is up +10.89% year-over-year
How far is ROIV quarterly EBITDA from its all-time high?
ROIV quarterly EBITDA is currently -143.85% below its historical high of -$125.20M set on March 31, 2022
How does ROIV quarterly EBITDA rank versus sector peers?
ROIV quarterly EBITDA is higher than 0.27% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
TTM EBITDA
-$1.15B$37.32M+3.16%
Summary
- Current Value
- As of today, ROIV TTM EBITDA is -$1.15B, up +3.16% on
- Historical Performance
- ROIV TTM EBITDA is down -17.62% year-over-year, and down -23.42% over the past 3 years
- All-Time High Comparison
- ROIV TTM EBITDA is currently -213.16% below its historical high of -$365.67M set on
- 3-Year Low Comparison
- ROIV TTM EBITDA is +3.16% above its 3-year low of -$1.18B reached on
- Sector Comparison
- ROIV TTM EBITDA is higher than 0.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$1.15B | +3.2% | -17.6% | -23.4% | -213.2% | |
| Annual EBITDA | -$1.11B | – | -35.9% | -21.5% | – | |
| Quarterly EBITDA | -$305.31M | -7.6% | +10.9% | -10.7% | +16.5% | |
| Price | $23.19 | +43.1% | +115.9% | +134.9% | +121.5% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $20.33M | -12.5% | -45.1% | -59.7% | +34.2% | |
| TTM EPS | -$0.55 | +20.9% | -109.8% | +67.5% | +75.9% | |
| TTM EBIT | -$1.15B | +3.0% | -17.1% | -22.9% | -112.7% | |
| TTM Net Income | -$901.27M | +7.3% | -118.9% | +28.9% | -60.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.03B | N/A | -11.4% |
| 3Y | -$832.64M | -37.5% | |
| 5Y | -$365.67M | -213.2% | |
| All | -$365.67M | -213.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.18B | +3.2% | |
| 3Y | -$1.18B | +3.2% | |
| 5Y | -$1.45B | +21.0% | |
| All | -$1.45B | +21.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ROIV?
As of today, ROIV TTM EBITDA is -$1.15B
What is ROIV TTM EBITDA most recent change?
ROIV TTM EBITDA was up +3.16% on September 30, 2025
What is 1-year change in ROIV TTM EBITDA?
ROIV TTM EBITDA is down -17.62% year-over-year
How far is ROIV TTM EBITDA from its all-time high?
ROIV TTM EBITDA is currently -213.16% below its historical high of -$365.67M set on March 31, 2021
How does ROIV TTM EBITDA rank versus sector peers?
ROIV TTM EBITDA is higher than 0.27% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ROIV Official Website roivant.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1635088/000163508825000016/0001635088-25-000016-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1635088/000114036125020715/0001140361-25-020715-index.htm
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv